Medication adherence-Key considerations for clinical pharmacologists

doi:10.1111/bcp.14228

Editorial

. 2020 Apr;86(4):628-629.

doi: 10.1111/bcp.14228. Epub 2020 Feb 25.

Medication adherence-Key considerations for clinical pharmacologists

Dyfrig A Hughes¹

Affiliations

Affiliation

¹ Centre for Health Economics and Medicines Evaluation, Bangor Institute for Health and Medical Research, Ardudwy Building, Normal Site, Bangor University, Bangor, UK.

PMID: 32100316
PMCID: PMC7098858
DOI: 10.1111/bcp.14228

Editorial

Medication adherence-Key considerations for clinical pharmacologists

Dyfrig A Hughes. Br J Clin Pharmacol. 2020 Apr.

. 2020 Apr;86(4):628-629.

doi: 10.1111/bcp.14228. Epub 2020 Feb 25.

Author

Dyfrig A Hughes¹

Affiliation

¹ Centre for Health Economics and Medicines Evaluation, Bangor Institute for Health and Medical Research, Ardudwy Building, Normal Site, Bangor University, Bangor, UK.

PMID: 32100316
PMCID: PMC7098858
DOI: 10.1111/bcp.14228

No abstract available

PubMed Disclaimer

Cited by

Telemedicine as a Tool to Improve Medicine Adherence in Patients with Affective Disorders - A Systematic Literature Review.
Leiz M, Pfeuffer N, Rehner L, Stentzel U, van den Berg N. Leiz M, et al. Patient Prefer Adherence. 2022 Dec 30;16:3441-3463. doi: 10.2147/PPA.S388106. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 36605330 Free PMC article. Review.
Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing.
Li ZR, Wang CY, Lin WW, Chen YT, Liu XQ, Jiao Z. Li ZR, et al. Neurology. 2023 Feb 28;100(9):e921-e931. doi: 10.1212/WNL.0000000000201604. Epub 2022 Nov 30. Neurology. 2023. PMID: 36450606 Free PMC article.

References

1. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691‐705. - PMC - PubMed
1. El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268‐279. - PMC - PubMed
1. Aznar‐Lou I, Fernández A, Gil‐Girbau M, et al. Initial medication non‐adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. Br J Clin Pharmacol. 2017;83(6):1328‐1340. - PMC - PubMed
1. Avataneo V, De Nicolò A, Rabbia F, et al. Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018;84(11):2535‐2543. - PMC - PubMed
1. de Jager RL, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY investigators . Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18‐24. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691‐705. - PMC - PubMed

[2] Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691‐705. - PMC - PubMed

[3] El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268‐279. - PMC - PubMed

[4] El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268‐279. - PMC - PubMed

[5] Aznar‐Lou I, Fernández A, Gil‐Girbau M, et al. Initial medication non‐adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. Br J Clin Pharmacol. 2017;83(6):1328‐1340. - PMC - PubMed

[6] Aznar‐Lou I, Fernández A, Gil‐Girbau M, et al. Initial medication non‐adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. Br J Clin Pharmacol. 2017;83(6):1328‐1340. - PMC - PubMed

[7] Avataneo V, De Nicolò A, Rabbia F, et al. Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018;84(11):2535‐2543. - PMC - PubMed

[8] Avataneo V, De Nicolò A, Rabbia F, et al. Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018;84(11):2535‐2543. - PMC - PubMed

[9] de Jager RL, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY investigators . Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18‐24. - PMC - PubMed

[10] de Jager RL, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY investigators . Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18‐24. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Medication adherence-Key considerations for clinical pharmacologists

Affiliation

Medication adherence-Key considerations for clinical pharmacologists

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources